BA
LUMO

BlackRock Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

BlackRock Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$657K Buy
7,100
+2,816
+66% +$317K ﹤0.01% 2059
2016
Q3 		$579K Buy
4,284
+124
+3% +$12.3K ﹤0.01% 2105
2016
Q2 		$422K Buy
4,160
+7
+0.2% +$868 ﹤0.01% 2209
2016
Q1 		$680K Buy
4,153
+2,813
+210% +$570K ﹤0.01% 1934
2015
Q4 		$439K Sell
1,340
-373
-22% -$121K ﹤0.01% 2153
2015
Q3 		$552K Sell
1,713
-3,948
-70% -$1.73M ﹤0.01% 2129
2015
Q2 		$2.26M Buy
5,661
+4,320
+322% +$1.84M ﹤0.01% 1221
2015
Q1 		$661K Buy
1,341
+205
+18% +$79.4K ﹤0.01% 1868
2014
Q4 		$406K Sell
1,136
-56
-5% -$16.7K ﹤0.01% 2148
2014
Q3 		$230K Buy
1,192
+261
+28% +$57.4K ﹤0.01% 2527
2014
Q2 		$222K Sell
931
-142
-13% -$28.9K ﹤0.01% 2569
2014
Q1 		$274K Buy
1,073
+140
+15% +$42.8K ﹤0.01% 2464
2013
Q4 		$185K Buy
933
+68
+8% +$12.1K ﹤0.01% 2704
2013
Q3 		$146K Buy
865
+13
+2% +$2.09K ﹤0.01% 2728
2013
Q2 		$151K Buy
+852
New +$121K ﹤0.01% 2636

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Advisors's LUMO Position: Q4 2016 in Review

BlackRock Advisors increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 66% in Q4 2016, buying an estimated $317K and bringing the position to 7,100 shares worth $657K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

BlackRock Advisors first reported a position in LUMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.26M in Q2 2015. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

  • BlackRock Advisors held 7,100 shares of Lumos Pharma, Inc. Common Stock worth $657K as of Q4 2016.
  • BlackRock Advisors bought 2,816 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $317K.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2059 holding.
  • BlackRock Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Lumos Pharma, Inc. Common Stock position peaked at $2.26M in Q2 2015.
  • 122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.